Investment
Features
FeesSafety
Academy
More
Pluang+

U.S. and Korean stock tokens launch on Arbitrum, tradable via Uniswap Apps on Ethereum layer-2.

Market News
07 Oct 2026
Tokenpost
View Source
Neutral
U.S. and Korean stock tokens launch on Arbitrum, tradable via Uniswap Apps on Ethereum layer-2.

Stove Finance has launched tokenized equities for U.S. and South Korean stocks on the Arbitrum Ethereum layer-2 network. These stock tokens are now available for trading through Uniswap Apps, supported by UniswapX, enabling easier access to tokenized shares from both markets. This development expands the availability of digital assets linked to traditional equities on blockchain platforms, potentially increasing liquidity and investor participation.

Stove Finance's launch of U.S. and Korean stock tokens on Arbitrum provides a new avenue for digital asset trading. For readers following the broader crypto market, here is Pluang's market snapshot as of Oct 07, 2026 21:23 WIB: out of 50 major cryptocurrencies, 5 rose and 43 fell today. Notable movers include SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, ENJ (Enjin Coin) down 11.93% at Rp523 with 69% sell order activity, and EGLD (MultiversX) down 11.73% at Rp71,582 with 57% sell order activity and a typical hold time of 85 days.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App